MAPT and Alzheimer disease: Because CSF concentration of sTREM2 correlates with CSF levels of total tau and phospho-tau, possibly being a biomarker for neurodegeneration [47,53], we verified whether TREM2 expression on peripheral immune cells and sTREM2 plasma concentration could be used as easily accessible peripheral biomarkers for the onset and/or progression of AD.